Literature DB >> 23283596

Patients' adherence to secondary prevention pharmacotherapy after acute coronary syndromes.

Yaman Kassab1, Yahaya Hassan, Noorizan Abd Aziz, Omar Ismail, Hadeer AbdulRazzaq.   

Abstract

BACKGROUND: Secondary prevention pharmacotherapy improves outcomes after acute coronary syndrome (ACS). However, poor medication adherence is common, and various factors play a role in adherence.
OBJECTIVES: The purpose of this study was to evaluate patients' level of adherence to evidence-based therapies at an average of 6 months after discharge for acs and to identify factors associated with self-reported non-adherence.
SETTING: This prospective study was conducted in the outpatient cardiac clinics of Hospital Pulau Pinang, located in Penang Island, a northern state in Malaysia.
METHOD: A random sample of ACS patients (n = 190) who had been discharged on a regimen of secondary preventive medications were included in this study. Six months after discharge and during their scheduled follow-up appointments to cardiac clinics, patients were interviewed using the translated eight-item Morisky Medication Adherence Scale. MAIN OUTCOME MEASURE: self-reported patients' adherence to medication.
RESULTS: Six months following their hospital discharge, only 35 patients (18.4 %) reported high adherence. Medium adherence was reported in majority of patients (51.1 %). Low adherence was reported in 58 patients (30.5 %). Forgetfulness was the most frequently reported reason for patients' non-adherence to their medications (23.2 %). Furthermore, this study identified 5 factors-namely age, employment status, ACS subtypes, number of comorbidities, and number of prescription medications per day-that may influence Patients' level of adherence to the prescribed regimens.
CONCLUSIONS: Our findings revealed a problem of non-adherence to secondary prevention medications among patients with ACS in Malaysia. Furthermore, this study demonstrates that older patients, unemployed patients, patients with more comorbid conditions, and those receiving multiple medications are less likely to adhere to their prescribed medications 6 months after hospital discharge.

Entities:  

Mesh:

Year:  2013        PMID: 23283596     DOI: 10.1007/s11096-012-9735-y

Source DB:  PubMed          Journal:  Int J Clin Pharm


  24 in total

Review 1.  Task force #4--adherence issues and behavior changes: achieving a long-term solution. 33rd Bethesda Conference.

Authors:  Ira S Ockene; Laura L Hayman; Richard C Pasternak; Eleanor Schron; Jacqueline Dunbar-Jacob
Journal:  J Am Coll Cardiol       Date:  2002-08-21       Impact factor: 24.094

Review 2.  Adherence to medication among chronic patients in Middle Eastern countries: review of studies.

Authors:  A Al-Qasem; F Smith; S Clifford
Journal:  East Mediterr Health J       Date:  2011-04       Impact factor: 1.628

3.  Decade-long changes in the use of combination evidence-based medical therapy at discharge for patients surviving acute myocardial infarction.

Authors:  Frederick A Spencer; Darleen Lessard; Jorge Yarzebski; Joel M Gore; Robert J Goldberg
Journal:  Am Heart J       Date:  2005-10       Impact factor: 4.749

4.  Compliance with and dosing of angiotensin-converting-enzyme inhibitors before and after hospitalization.

Authors:  C M Roe; B R Motheral; F Teitelbaum; M W Rich
Journal:  Am J Health Syst Pharm       Date:  2000-01-15       Impact factor: 2.637

Review 5.  Medication compliance: a healthcare problem.

Authors:  J S Berg; J Dischler; D J Wagner; J J Raia; N Palmer-Shevlin
Journal:  Ann Pharmacother       Date:  1993-09       Impact factor: 3.154

Review 6.  Effects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: a systematic review.

Authors:  Koon K Teo; Salim Yusuf; Marc Pfeffer; Christian Torp-Pedersen; Lars Kober; Alistair Hall; Janice Pogue; Roberto Latini; Rory Collins
Journal:  Lancet       Date:  2002-10-05       Impact factor: 79.321

7.  Factors associated with medication noncompliance in rural elderly hypertensive patients.

Authors:  C G McLane; S J Zyzanski; S A Flocke
Journal:  Am J Hypertens       Date:  1995-02       Impact factor: 2.689

8.  Does beta-blocker therapy improve clinical outcomes of acute myocardial infarction after successful primary angioplasty?

Authors:  Steven J Kernis; Kishore J Harjai; Gregg W Stone; Lorelei L Grines; Judith A Boura; William W O'Neill; Cindy L Grines
Journal:  J Am Coll Cardiol       Date:  2004-05-19       Impact factor: 24.094

9.  The relationship of treatment adherence to the risk of death after myocardial infarction in women.

Authors:  E J Gallagher; C M Viscoli; R I Horwitz
Journal:  JAMA       Date:  1993-08-11       Impact factor: 56.272

10.  Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial.

Authors:  Patrick W J C Serruys; Pim de Feyter; Carlos Macaya; Norbert Kokott; Jacques Puel; Matthias Vrolix; Angelo Branzi; Marcelo C Bertolami; Graham Jackson; Bradley Strauss; Bernhard Meier
Journal:  JAMA       Date:  2002-06-26       Impact factor: 56.272

View more
  4 in total

1.  Feasibility and Acceptability of a Positive Psychological Intervention for Patients With Type 2 Diabetes.

Authors:  Christina M DuBois; Rachel A Millstein; Christopher M Celano; Deborah J Wexler; Jeff C Huffman
Journal:  Prim Care Companion CNS Disord       Date:  2016-05-05

Review 2.  Evidence of poor adherence to secondary prevention after acute coronary syndromes: possible remedies through the application of new technologies.

Authors:  Kevin Cheng; Nicola Ingram; Jan Keenan; Robin P Choudhury
Journal:  Open Heart       Date:  2015-01-24

Review 3.  Accuracy of a screening tool for medication adherence: A systematic review and meta-analysis of the Morisky Medication Adherence Scale-8.

Authors:  Sun Jae Moon; Weon-Young Lee; Jin Seub Hwang; Yeon Pyo Hong; Donald E Morisky
Journal:  PLoS One       Date:  2017-11-02       Impact factor: 3.240

4.  Medication adherence and its determinants in patients after myocardial infarction.

Authors:  Łukasz Pietrzykowski; Piotr Michalski; Agata Kosobucka; Michał Kasprzak; Tomasz Fabiszak; Wioleta Stolarek; Jolanta M Siller-Matula; Aldona Kubica
Journal:  Sci Rep       Date:  2020-07-21       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.